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Although B cells and antibodies are the central effectors of humoral immunity, B cells can
also produce and secrete cytokines and present antigen to helper T cells. The uptake of
antigen is mainly mediated by endocytosis; thus, antigens are often presented by MHC-II
molecules. However, it is unclear if B cells can present these same antigens via MHC-I
molecules. Recently, Salmonella bacteria were found to infect B cells, allowing possible
antigen cross-processing that could generate bacterial peptides for antigen presentation
via MHC-I molecules. Here, we will discuss available knowledge regarding Salmonella anti-
gen presentation by infected B cell MHC-I molecules and subsequent inhibitory effects on
CD8+ T cells for bacterial evasion of cell-mediated immunity.
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INTRODUCTION
Salmonella typhi is the causative agent of typhoid fever in
human beings, while infection with Salmonella enterica serovar
Typhimurium (Salmonella typhimurium) produces a systemic ill-
ness in mice similar to that in human beings (1). In susceptible
mice, the bacteria reside inside Salmonella-containing vacuoles
(SCVs) of neutrophils, macrophages, and dendritic cells, in which
they replicate, resist killing, and induce systemic disease (2–5).
Uptake of Salmonella is mediated by the coordinated action of
several virulence proteins translocated through the type III secre-
tion system (T3SS), encoded by genes of Salmonella pathogenicity
islands (SPIs) (6). While SPI-1 genes encode T3SS translocated
proteins essential during bacterial invasion, T3SS SPI-2 genes are
expressed once the bacteria are within the phagosome (7).
The bacteria exploit several types of immune cells for long-
term survival (8–10). To survive within these cells and promote
colonization, the bacteria release several virulence proteins that
alter host cell functions, such as cytoskeletal architecture, mem-
brane trafficking, signal transduction, cell death, cell trafficking,
and cytokine gene expression (5, 6). This review focuses on the
role of B cells during Salmonella infection, specifically as a niche
from which the bacteria can evade immune responses and survive
long-term within the host.
GENERAL ANTIGEN PROCESSING AND PRESENTATION
Antigen location influences its proteolytic processing pathway and
its access to different classes of MHC molecules. Subsequent pre-
sentation of these antigens by MHC-I or MHC-II molecules is nec-
essary to induce a T cell immune response. Extracellular antigens
are captured by antigen-presenting cells (APCs) through phago-
cytosis, macropinocytosis, or endocytosis. Newly formed phago-
somes containing antigen undergo progressive trafficking char-
acterized by acquiring or losing endosomal markers to generate
a mature phagosome. Finally, their fusion with lysosomes allows
complete degradation of their cargo due mainly to serine proteases
(cathepsins) (11). Assembly of peptide/MHC-II complexes takes
place in a multilamellar endosomic compartment that contains
newly synthesized MHC-II molecules bound with invariant chain-
peptide (CLIP) and machinery necessary for efficient peptide
loading. The acidic environment facilitates the exchange of CLIP
for antigenic peptide, catalyzed by H-2M in mice or HLA-DM in
human beings. Recycled MHC-II molecules from the cell surface
can also be used to form peptide-MHC-II complexes. Then, the
peptide-MHC-II complexes newly formed are transported to the
plasma membrane. Finally, effective MHC-II presentation requires
clustered peptide/MHC-II complexes at the APC surface that can
subsequently interact with the T cell receptor (TCR) and CD4
co-receptor (11, 12).
Alternately, intracellular antigens in the majority of cells are
processed within the cytosol by proteosomal degradation. The
peptide fragments are then translocated to the endoplasmic retic-
ulum (ER) lumen by the transporter associated with presentation.
Nascent MHC-I molecules and β2-microglobulin associate with
the ER proteins tapasin, calreticulin, and Erap57, which allows gly-
cosylation of MHC-I and optimal folding necessary after peptide
binding. Then newly peptide/MHC-I complexes are transported
to the cell surface (12, 13). Stable heterotrimeric complexes are
necessary to engage the TCR and CD8 co-receptor. However, extra-
cellular antigens localized in vesicular compartments of APCs can
also be efficiently presented by MHC-I molecules (14), a process
known as cross-presentation or cross-priming. At least four routes
for cross-priming have been described (15): (1) the cytosolic
route requires peptide translocation from the phagosomes to
the cytosol for their proteosomal processing and subsequent ER
translocation (16); (2) the vacuolar route involves peptides gen-
erated within the phagosome be loaded in intravacuolar-recycled
www.frontiersin.org November 2014 | Volume 5 | Article 586 | 1
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Lopez-Medina et al. Persistent Salmonella regulate B cell activity
MHC-I molecules (17); (3) the antigen is cross-processed through
a phagosome-cytosol-phagosome alternating pathway (18); and
(4) peptides are processed in a previously non-characterized endo-
cytic compartment, secreted into the cytosol, and loaded onto
empty MHC-I molecules on the surfaces of macrophages and
bystander cells (19, 20).
SALMONELLA INTERFERES WITH ANTIGEN-PROCESSING
MECHANISMS
Salmonella evade acquired immune responses to establish a
chronic infection (21, 22). T cell responses can be inhib-
ited by impaired APC antigen processing and presentation
caused by bacterial proteins encoded by SPI-2 genes. As men-
tioned previously, Salmonella interferes with normal cell traf-
ficking; for example, Salmonella protein SpiC inhibits matura-
tion of Salmonella-containing phagosomes into phagolysosomes
in macrophages and dendritic cells (2, 23–25). In addition, the
phosphoinositide phosphatase SopB modulates vesicular traffick-
ing (26). This virulence protein manipulates membrane surface
charges of nascent SCVs by reducing levels of the negatively
charged lipids phosphatidylinositol-4-5-biphosphate and phos-
phatidylserine, thus resulting in SCV maturation (27). Inhibition
of phagosome acidification has been observed in macrophage cell
lines (e.g., IC21) and may impede the proteolitic activity of cathep-
sins residing in late-endosomal compartments; this mechanism
could also modify peptide processing prior to presentation (28).
The integrity of the SCV, attributed to SifA, is also crucial for
its resistance to oxidative killing mediated by the phagocyte oxi-
dase phox (2). Salmonella mutants defective in SPI-1 and SPI-2
genes show reduced proliferation within macrophages, indicat-
ing these gene products could limit the source of peptides for
antigen presentation, resulting in delayed T cell responses (29,
30). In support of this finding, Helaine et al. recently used flu-
orescent dilution to study intracellular replication of bacteria to
determine the vacuolar environment induces phenotypic hetero-
geneity, thereby explaining the presence of non-replicating, yet
persistent, Salmonella that could provide a reservoir for relapsing
infection (31). Additionally, studies in human beings reveal the
bacteria can control surface MHC-II expression through ubiquiti-
nation (32). Thus, Salmonella can impair antigen processing and
presentation steps at multiple levels to prevent activation of T cell
responses.
SALMONELLA EVADE T CELL RESPONSES
An immunosuppressive effect on T cells, both dependent and
independent of bacteria, has been observed during Salmonella
infection. Basel Al-Ramaldi first noted this effect in macrophages
infected with an attenuated strain of Salmonella cultured with
splenocytes in transwell plates. Soluble factors mediated T cell sup-
pression, but the exact nature of the factor(s) was not determined
at that time (33). Later, T cell proliferation assays were performed
in the presence or absence of the inducible nitric oxide synthase
(iNOS) inhibitor l-NMMA, which showed the suppression is also
mediated by dendritic cells and is dependent on NOS induction
(34). When nitric oxide was blocked with aminoguanidine, the
inhibition of T cell suppression, macrophage activity, and poly-
morphonuclear leukocyte influx was observed (35). Thus, nitric
oxide may play multiple biological roles during Salmonella infec-
tion. Other studies employing the human-restricted strain S. typhi
showed the polysaccharide Vi, released from Salmonella, leads to
an impairment of IL-2 production in T cells by interacting with the
membrane prohibitin complex (36). Other transwell assays with
CD8+ T cells and dendritic cells infected with Salmonella deficient
in the proteins SPI-1, SPI-2, phoP, and sti or carrying virulence
plasmids demonstrated priming can be inhibited by direct contact
with the bacteria (37). Moreover, exposure to LPS during priming
in Salmonella-infected mice suppressed IL-2 and TNF-α produc-
tion of flagellin-specific CD4+ T cells, resulting in exacerbation of
murine typhoid (38).
Other mechanisms for T cell evasion Salmonella infection have
been described. Experiments involving adoptive transfer of CD4+
T cells from TCR-transgenic mice into Salmonella-infected mice
showed the bacteria induce a progressive culling of newly activated,
high-avidity, antigen-specific CD4+ T cells that express higher
levels of programed death-ligand 1 (PD-L1) in an SPI-2 depen-
dent manner (39, 40). This mechanism reshapes the repertoire of
antigen-specific T cells after Salmonella infection. Furthermore,
several groups have found the bacteria are able to reach the thy-
mus (41, 42). We have observed that infections of the thymus cause
Vβ chain rearrangements of TCRs in single-positive CD8+ T cells,
possibly leading to a biased selection of certain types of clonal
cell populations (unpublished data). Salmonella can downregulate
TCR expression by reducing the amount of both surface and intra-
cellular TCR-β chain in T cells co-cultured with S. typhimurium
(43). However, it is unknown if the bacteria could trigger or pro-
duce crosstalk between signaling pathways that would lead to this
phenotype.
Because regulatory T (Treg) cells mediate immune suppression,
these cells can play both detrimental and protective roles in host
defense against infection. Johanns et al. has shown that suppres-
sive capacity of Treg coincide with a delay of elicing protective
response during early Salmonella infection, contrary during late
infection Treg suppressive potency diminish (44). Moreover, peri-
toneal NK1.1 αβ T cells reduced IL-12 production in macrophages
by secretion of IL-4 upon TCR activation, during the early phase
of Salmonella infection (45). Thus, Salmonella employ several
strategies to overcome acquired immunity in order to persist and
produce a chronic infection in the host.
B CELLS AS APCs IN T CELL PRIMING
The introduction of fluorescence-activated cell sorting (FACS)
revolutionized the study of B cells, allowing the classification of
B cells from lymph nodes, the spleen, and more recently, from
the liver (46) into phenotypically and functionally distinct pop-
ulations, denoted B1 and B2. The B2 lymphocytes are further
subdivided into marginal zone B (MZ-B) and follicular B (FO-
B) cells, while B1 lymphocytes are grouped as B1a or B1b cells.
All subsets differ in their development, location, function, and
most importantly, their ability to present antigens to T cells. For
B cells to become competent APCs, they first must receive sig-
nals either from the B cell receptor (BCR) or Toll-like receptors
(TLRs) for activation. This feature allows enhanced B cells uptake
of both soluble and particulate (phagocytosed) antigens, followed
by the expression of co-stimulatory molecules and the subsequent
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processing and presentation of antigens with MHC-I or MHC-II
molecules (47).
Marginal zone B cells are strategically located in the blood-
stream for easy activation and to intercept and react to blood-
borne antigens (48, 49). Antigens captured by MZ-B cells are
delivered to follicular dendritic cells through shuttling dependent
on the CXCR5-S1P1-S1P3 axis (50). However, MZ-B cells can also
initiate a rapid first line of defense, demonstrated by Olivier et al.,
in which they express higher basal levels of co-stimulatory mol-
ecules CD80 and CD86, which are rapidly upregulated within 6–
24 h after LPS exposure or BCR signaling. In fact, LPS-stimulated
MZ-B cells induced a vigorous proliferation of alloreactive T cells
in vitro, in contrast with LPS-stimulated FO-B cells, which then
developed into mature plasma cells (51). In another set of exper-
iments, Attanavanich et al. demonstrated that in vivo hen egg
lysozyme (HEL)-specific MZ-B cells are more potent activators
of naïve TCR-transgenic CD4+ T cells than HEL-specific FO-B
cells. The MZ-B cells likely have better access to the antigen and
can rapidly migrate toward the T cell area, followed by plasma
cell differentiation (52). Together, these experiments highlight the
role of MZ-B cells to provide a bridge between innate and adaptive
immune responses.
Similarly, B1 cells express higher basal levels of CD80 and CD86,
suggesting their potential role in rapidly initiating a T cell response
(53). The capability of peritoneal cavity B1 cells to phagocytose,
process, and present particulate antigens, such as OVA bound to
latex beads (1µM) (54). Interestingly, MZ-B cells, in conjunction
with B1 cells from either the spleen or peritoneal cavity, participate
in the response against blood-borne antigens (55). In addition to
MZ-B and B1 cells, parabiosis studies suggest that mature B cells
located in the perisinusoidal niche of bone marrow, which have
access to the circulatory system and can freely enter and exit the
bone marrow, are also specialized for T cell-independent responses
to blood-borne antigens (56). Previous paradigms describing B cell
antigen presentation have changed, further supported by recent
findings involving phagocytic IgM+ cells from teleost fish and
amphibians that indicate an evolutionary relationship between B
cells and macrophages (57). This theory suggests B cells may have
evolved from ancient phagocytic cells to macrophage-like cells to
B cells that maintained their ability to phagocytose. Therefore,
when B cells are activated, they become potent APCs when they
encounter specific antigens, leading to cognate T-B cell interac-
tions, T cell activation, and germinal center (GC) reactions. The
amount of antigen captured and presented by GC B cells to fol-
licular helper T (Tfh) cells is proportional to cell division and
hypermutation rates because GC B cells with the highest affinity
for antigens are selectively expanded and diversified (58).
In addition to priming T cells, APCs can also provide signals
that instruct T cells to enter into effector/memory differentiation
programs. Soo Choi et al. found that Tfh differentiation is medi-
ated by two key players; during priming, dendritic cells induce Bcl6
expression in Tfh cells, while the stable commitment to this differ-
entiation program requires interaction with FO-B cells (59). This
mechanism was explored by experiments in which antigen-specific
T cells from MD4/µMT B cell-deficient mice showed reduced
levels of Bcl6 expression at day 7 post-immunization against lym-
phocytic choriomeningitis virus (LCMV). Experiments using B
cell/dendritic cell MHC-II-deficient mice reinforced the role of
MHC-II in antigen presentation by FO-B cells in cooperation
with Tfh differentiation (60). This model suggested B cells par-
ticipate in the initiation, maintenance, and full polarization of
Tfh differentiation (61). Regarding Th1 differentiation, Barr et al.
have shown that an antigen-specific IgG2c primary response is
absolutely dependent on MyD88 signaling to B cells in mice immu-
nized with T cell-dependent antigen or in mice infected with
Salmonella (62). They also found that B cell-intrinsic MyD88
signaling is required for primary effector Th1 cell development,
whereas antigen-specific BCR-mediated presentation is necessary
for the development of Th1 memory cells against Salmonella (63).
In addition, MZ-B cells participate in Th1 cell differentiation, and
Attanavanich et al. found that, when cultured in vivo, HEL-primed
MZ-B cells from MD4 mice with naïve CD4+ T cells produce
large amounts of Th1-like cytokines and IFN-γ but low levels
of IL-4, IL-5, and IL-10. This expression pattern suggests MZ-
B cells also provide signals for Th1 cell development during the
primary immune response (52). These findings emphasize the
non-redundant role of B cells as programmers of CD4+ T cell
differentiation.
The ability of B cells to process and present viral antigens
to CD8+ T cells via MHC-I molecules was first explored by
Ciavarra et al. with proliferation and cytotoxicity assays using
[3H]thymidine and 51Cr release, respectively. These experiments
highlighted the efficacy of mitogen (LPS)-activated B cells in dis-
playing target antigens on their cell surface membranes, which are
efficiently recognized in a MHC-I-dependent manner by vesicu-
lar stomatitis virus-specific cytotoxic T cells (CTLs) (64). Other
experiments employing mice infected with LCMV-Clone 13, a
strain that causes persistent infections, showed that neutralizing
antibodies are induced unless CD8+ T cells were depleted. This
result suggests B cells might be actively infected and capable of
presenting viral peptides on MHC-I molecules; thus, they may
become targets for LCMV-specific CTLs (65). Subsequent stud-
ies by the same group used 51Cr release assays with splenocytes
from LCMV-infected BALB/c (H-2d) mice and as target, LCMV-
infected, neutralizing antibody-secreting hybridomas. Showed
that CTLs lysed the infected hybridomas, because LCMV was
endocytosed through the membrane-anchored neutralizing anti-
body receptor and are later eliminated by virus-specific CTLs (66).
These results reinforced the role of B-cell as APC. Although not
absolutely required, they do play a role in T cell priming, thus pos-
itively impacting the function of CD8+ T cells. Multiple cytokines,
such as IL-2, IL-12, IL-21, IL-27, and IL-33, which are produced by
CD4+ T cells, APCs, and non-hematopoietic cells from the T cell
zone, participate in promoting effector T cell differentiation (67,
68). Liu et al. first explored B cells’potential“helper role”for CD8+
T cells by evaluating the anti-influenza cytolytic activity of CD8+
T cells. They demonstrated that soluble factors released by B cells
could replace the CD4+ T cell requirement to induce cytotoxic
responses to influenza virus (69). These previous studies changed
our view of B cells as APCs and showed they strongly influence an
effective CD8+ T cell response against pathogens localized in the
cytoplasm, such as viruses.
Evidence that B cells possess machinery to perform alterna-
tive pathways for antigen processing for CD8+ T cell priming
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has been presented in studies related to vaccine development
and bacterial infections. For example, the Mycobacterium tuber-
culosis heat shock protein 70 (HSP70) is endocytosed, subjected
to vacuolar processing, and forms highly immunogenic com-
plexes with chaperoned peptides that are presented on MHC-I
molecules to elicit a CD8+ T cell response (70). In one experi-
ment, CpG oligodeoxynucleotides-activated B cells could uptake
OVA-associated HSP70, in a CD91-dependent manner, process
the fusion protein by vacuolar mechanisms and prime OVA-
specific CD8+ T cells. In another study involving immune-
stimulating complexes (ISCOMS) that induce strong MHC-I-
restricted responses, HEL-specific B cells could uptake OVA-HEL-
ISCOMS and then stimulate OVA-specific CD8+ T cell responses.
This cross-presentation required endosomal acidification, proteo-
somal processing, and classical MHC-I/peptide transport (71).
During bacterial infections, BCR-mediated internalization of Sal-
monella led to efficient antigen delivery to MHC-II antigen-
loading compartments; however, when the proteosome was inhib-
ited with MG-132, only a partial dependence on this protease was
observed (72, 73). These data indicate B cells may have machinery
to employ the phagosome-cytosol antigen presentation pathway.
In addition, our group has shown that Salmonella-infected B cells
cannot use the vacuolar alternative pathway that involves antigen
processing in a vacuolar compartment, which is often followed by
secretion and loading of antigenic peptides to MHC-I molecules
on the surface of B cells and bystander cells (28). In sum, these
studies show that B cells possess machinery necessary to induce a
CD8+ T cell response against intracellular pathogens localized in
vacuolar compartments.
We have thus far reviewed evidence that portrays B cells as
highly competent APCs that positively impact T cell functions;
however, B cells are also negative regulators of T cell responses
therefore denoted as Breg cells. Their inhibitory function has been
associated mainly with IL-10 because this B cell derived-cytokine
can protect against autoimmunity, yet increase the host’s suscep-
tibility to infection (74). Recently, two separate studies identified
an additional soluble factor that mediates regulatory functions
in B cells. One study found IL-35 can induce the conversion of
typical B cells into an IL-35-producing Breg cell population depen-
dent on STAT1 and STAT3, which are induced through signaling
by IL-12Rβ2 and IL-27Rα. In addition, induced B cells exerted
a suppressive influence on pathogenic Th17 and Th1 cells from
experimental autoimmune uveitis-induced mice (75). The second
study revealed that B cells, through activation of TLR4 and CD40,
secrete IL-35. This study focused on B35 cell-deficient mice and
found B cell-derived IL-35 is necessary for pathogenic Th17 and
Th1 cell suppression in an autoimmune encephalomyelitis model.
Moreover, a lack of IL-35 production by B cells led to increased
activation of macrophages and CD4+ Th1 cells and favored B cells
as APCs in a Salmonella infection model (76).
B CELLS DURING SALMONELLA INFECTION
T cells, particularly Th1 cells, are crucial for Salmonella infec-
tion control due to their IFN-γ secretion (62, 63, 77–81), while
Salmonella-specific antibodies are required to resist secondary
infection. The role of B cells as antibody-producing cells has been
demonstrated using B cell-deficient mice (Igh-6−/− or Igµ−/−)
(82, 83) that were immunized with an attenuated strain of Sal-
monella and then challenged with a virulent strain; these mice
could not resist the infection (84). In addition, transfer of immune
serum to immunized B cell-deficient mice (Igµ−/−) 1 day prior to
challenge with virulent Salmonella effectively reconstituted their
immunity (83). Thus, antibody-producing B cells are key play-
ers during secondary bacterial infections. Beyond this well-known
role, another study suggests B cells are required for priming T
cell responses during bacterial infections. Notably, Ugrinovic et al.
found a reduced frequency of both IFN-γ-producing CD4+ and
CD8+ T cells in immunized, gene-targeted, B cell-deficient Igh-
6−/− mice. When primary B cells infected in vitro were cultured
with Salmonella-specific CD4+ T cells from immunized mice, they
induced modest proliferation compared to in vitro-infected bone
marrow-derived macrophages (85). More recently, Nanton et al.
evaluated T cell responses against Salmonella using B cell-deficient
JhD mice, transgenic mice with B cells that could not class switch or
secrete antibodies, and mice with B cells that could not class switch
but were able to secrete IgM. They observed a decrease of both IFN-
γ +CD8+ or CD4+ T cells, which suggested antibodies are not
required for an optimal Salmonella-induced Th1 response (86).
Collectively, these studies show that in vitro Salmonella-infected
B cells can moderately prime CD4+ T cells and somehow partici-
pate in the activation of T cell responses. Recent findings from Barr
et al. using a Salmonella infection model demonstrated intrinsic
MyD88-derived B cell signals play a role in effector Th1 cell differ-
entiation (62, 63). Our group, along with others, has shown that
in vitro-infected B cells produce IL-6 (87), which contributes to the
early multistages of Tfh cell differentiation. Therefore, it is not sur-
prising that B cells can also act as T cell programmers, although
it is unknown if B cell infection may impair the multistage and
multifactorial Tfh cell differentiation program.
B CELLS PRIME CD8+ T CELLS RESPONSES DURING
SALMONELLA INFECTION
Although CD4+ T cells are known as key players during Salmonella
infection, the role of CD8+ T cell responses is less clear. Interest-
ingly, CD8+ T cells participate in the eradication of bacteria during
secondary Salmonella infections, but their role in primary infec-
tion seems contradictory (80, 88, 89). Previous evidence demon-
strated a null to modest participation of CTLs in mice deficient
of β2m or depleted of CD8+ T cells (80, 89). More recent reports
focused on MHC-Ia-deficient mice (KbDb) demonstrated the role
of CD8+ T cells during the later stages of a primary infection
(88). In addition, the involvement of non-polymorphic MHC-Ib
(Qa-1, HLA-E, H2-M3) during the response against Salmonella
has recently gained attention due to their role as presentation
molecules for Salmonella antigens (90, 91).
When acting as APCs, B cells that express a Salmonella-specific
BCR can, after bacterial internalization, reactivate human mem-
ory CD8+ T cells via cross-presentation, leading to a CTL response
(72). However, it is unclear if primary B cells infected with Sal-
monella by the natural entry pathway could cross-process and
present Salmonella antigens via MHC-I. By using a Salmonella
strain (S-OVA) that expresses the OVA peptide (OVAp) fusioned
with the curli protein (Crl), we evaluate whether MHC-I present
Salmonella antigens after infection. We found that in vitro and
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FIGURE 1 | Proteasome and paghosomal degradation are involved for
cross-processing of Salmonella antigens by B cells. Model of
cross-priming in Salmonella-infected B cells. Salmonella infection generates
antigens that are translocated to the cytosol for proteosomal processing
and subsequent translocation of Salmonella peptides by TAPs to ER for
loading MHC-I. Degradation of Salmonella proteins with the SCV generate
peptides that load recycled MHC-I molecules and the resulting
MHC-I/peptide complexes are then transported to the B cell surface.
in vivo S-OVA-infected B cells express Kb-OVAp complexes. This
presentation diminished by using inhibitors of the components
of the classical (brefeldin and lactacystin) or vacuolar (leupeptin
and ammonium chloride) pathways suggesting that processing
of Salmonella antigens might involve the translocation of par-
tial processed antigens from the SVC to the cytosol, followed by
their proteosomal degradation and subsequent ER translocation
(Figure 1) (unpublished data). In agreement with our results,
a previous study demonstrated that, in human-specific B cells,
cross-presentation of Salmonella antigens is partly proteosome-
dependent (72). It is also likely that peptides generated within
the SCV might load onto recycling MHC-I molecules (Figure 1).
On the other hand, Salmonella infection also promotes B cell
activation since expression of co-stimulatory molecules such as
CD40, CD80, and CD86 within Salmonella-infected B cells is
observed (unpublished data). In sum, these results suggest that
infected B cells are capable of cross-processing and presenting
Salmonella antigens and can express co-stimulatory molecules
to become professional APCs that prime and sustain a CD8+ T
cell response. Similarly, other studies employing antigen-specific
B cells in Salmonella infection or diabetes type-1 models further
support the capability of B cells to process and present exogenous
antigens (72, 92).
B CELLS AS TROJAN HORSES DURING SALMONELLA
INFECTION
We and other groups have demonstrated that S. typhimurium
infects and persists long-term in splenic and lymph node
macrophages, splenic dendritic cells, splenic B cells, bone marrow
B cell precursors, and plasma cells. Studies in human beings have
shown that S. typhi can be isolated from bone marrow cultures,
regardless of disease stage or type of pharmacological treatment
(93). Bone marrow B cells present a safe niche for Salmonella
because they cannot enter peripheral circulation until they fully
mature. In human beings and mice, most Salmonella infections
occur in the ileum, spleen, and liver (94). More recently, gall-
stone biofilms and the gallbladder epithelium were demonstrated
niches for chronic Salmonella infections; however, only 3–5% of
S. typhi-infected individuals develop a chronic infection in these
sites (21, 95).
Macrophages often serve as host cells for Salmonella during
acute and chronic infections, but the fate of these cells, as well as
other infected cells, is unclear. In some cases, Salmonella induce
host cell death, releasing the bacteria and disseminating the infec-
tion. Our group has shown that Salmonella inhibit pyroptosis in B
cells because they abrogate IL-1β production by impairing NLRC4
transcription; thus, B cell death is not induced (87, 96). This mech-
anism could allow Salmonella survival within these cells during an
innate immune response. Using the B cell line A20, we discovered
the vacuolar compartment in which Salmonella reside is different
from that in macrophages (28). Interestingly, fluorescent dilu-
tion analysis revealed that the SCV environment and nutritional
deprivation of infected macrophages activate Salmonella virulence
genes, leading to the presence of non-replicating, persistent bacte-
ria (31). In B cells, primary infection is followed by the production
of reactive oxygen species, iNOS, and pro-inflammatory cytokines
IL-1β, TNF-α, and IL-6, which often control the bacteria (87). Sal-
monella replication rates within infected B cells are likely low, as we
and other groups have found very few bacteria in these cells. For
example, Souwer et al. used in vitro infection assays to determine
that only 4% of human B cells phagocytose the bacteria via their
BCR (73). Similarly, we have observed approximately 0.1–1% of
mouse splenic primary B cells, bone marrow B cell precursors, and
plasma cells get infected with Salmonella. However, we also dis-
covered that after 2 months post-infection, Salmonella can still be
isolated from infected bone marrow B cell precursors and infected
plasma cells (97). Our experiments involving susceptible BALB/c
mice infected with a single dose of 50 virulent Salmonella bacteria
showed that after 1 month post-infection, bacterial CFUs could be
isolated from infected splenic B1a and B1b, MZ-B, and FO-B cells
(unpublished data). Thus, Salmonella likely exploit B cell popula-
tions to persist long-term in the host. Interestingly, if Salmonella
infect and persist within all splenic B2 cells, infected FO-B cells,
which possess migratory properties, could as act as carriers for fur-
ther dissemination of Salmonella. Moreover, plasma cells migrate
to the bone marrow and eventually undergo apoptosis (98), but
these cells could also be involved in spreading the bacteria. How-
ever, it is unknown if infected splenic B cells could also differentiate
into antibody-secreting cells.
The microbes’ level of persistence depends on a balance between
the immune response of the host and the bacteria’s ability to sur-
vive within the cell. Certain viral pathogens (LCMV, HIV, HCV,
HBV) (99–102), parasites (Trypanosoma cruzi, Schistosoma man-
soni, Tenia crassiceps) (103–105), and some bacteria (M. tubercu-
losis, Helicobacter pylori, Chlamydia trachomatis) (106–108) can
render T cell responses ineffective by benefiting from inhibitory
stimuli such as PD-1:PD-L (PD-L1 and PD-L2) interactions. Some
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of the experiments described above showed B cells can process
and present Salmonella antigens in vitro and in vivo. In addition,
we have found that B cells remain infected long-term, suggest-
ing they may avoid elimination by CTLs. In this context, PD-L1
and PD-L2 expression in B cells infected in vitro and in vivo with
Salmonella was observed (unpublished data). These results suggest
Salmonella infection provides signals that trigger the transcription
of PD-L1 and PD-L2 genes. Furthermore, infected B cells likely
produce both positive and inhibitory signals. These inhibitory sig-
nals may be more dominant during infection because they allow
the bacteria to avoid effector CD8+ T cell responses. Therefore,
expression of PD-L1 and PD-L2 by infected B cells could be one
possible mechanism employed by the bacteria to survive within
these cells and evade cell-mediated immunity. However,no current
evidence indicates the PD-1:PD1-Ls axis directly terminates or
attenuates CD8+ T cell responses during chronic Salmonella infec-
tion. Our current studies simply show that Salmonella-infected B
cells express PD1-Ls during acute and chronic infections. We have
also found that PD-1 is expressed on antigen-specific CD8+ T
cells (unpublished data), so the participation of this axis during
infection could explain why previous studies reported no sig-
nificant CD8+ T cell involvement during Salmonella infections.
Furthermore, our group has also found B1 cells can produce IL-
10 when infected in vitro with virulent Salmonella (unpublished
data), which, along with IL-35 production, can inhibit both innate
and acquired immune responses against Salmonella (76, 109).
CONCLUDING REMARKS
Many studies have sought to elucidate how Salmonella achieves a
balance between avoiding immune responses and surviving long-
term in its host. Previous research indicates Salmonella exploits
several types of immune cells to persist during chronic infections.
Here, we presented evidence that B cells are an amenable bacterial
reservoir, promoting their persistence, dissemination, and evasion
of CD8+ T cell-mediated responses. Identifying the mechanisms
employed by Salmonella-infected B cells to avoid cell-mediated
immunity is clinically significant for understanding the chronic,
asymptomatic carrier stage of Salmonella infection that occurs in
human beings following typhoid fever.
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